Guilty as CHARGED: p53's expanding role in disease
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Unrestrained p53 activity during development, as occurs upon loss of the p53 negative regulators Mdm2 or Mdmx, causes early embryonic lethality. Surprisingly, co-expression of wild-type p53 and a transcriptionally-dead variant of p53, with mutations in both transactivation domains (p53(L25Q,W26S,F53Q,F54S)), also causes lethality, but later in gestation and in association with a host of very specific phenotypes reminiscent of a syndrome known as CHARGE. Molecular analyses revealed that wild-type p53 is inappropriately activated in p53(5,26,53,54/)(+) embryos, triggering cell-cycle arrest or apoptosis during development to cause CHARGE phenotypes. In addition, CHARGE syndrome is typically caused by mutations in the CHD7 chromatin remodeler, and we have shown that activated p53 contributes to phenotypes caused by CHD7-deficiency. Together, these studies provide new insight into CHARGE syndrome and expand our understanding of the role of p53 in diseases other than cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“strain, a C-terminal fragment of p53 is produced, provoking premature aging in p53m/C adults.(84) However, unlike the p5325,26,53,54/C embryos, there is no sign of increased basal p53 activity, and instead, stress signals are required to induce the p53 m protein to augment p53 stability and activity.”
BackgroundRescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 2×
“These observations provided the first demonstration that unrestrained p53 activity during development can drive embryonic lethality.(13,15,16) Similarly, Mdmx¡/¡ mice are Keywords: p53, transcriptional activation, CHARGE syndrome, CHD7, embryonic development, Ribosomopathy, Mdm2, neural Crest”
BackgroundSchwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · cited 1×
“p53 is a transcriptional activator, which binds to specific DNA elements throughout the genome, leading to the induction of p53 target genes involved in the apoptosis or cell-cycle arrest programs, although p53 can also act through transactivation-independent mechanisms such as direct induction of apoptosis through cy…”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“A direct role for p53 in triggering phenotypes upon telomere erosion is indicated by studies in telomerasedeficient mice, where germ cell depletion is partially rescued by p53 loss.(69) While telomere attrition clearly induces DNA damage, thereby activating p53, some effects may also be through ribosome biogenesis def…”
BackgroundModulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586 · cited 2×
“Another mouse strain, overexpressing a truncated, naturally-occurring isoform of p53 that lacks the first transactivation domain (D40), also exhibits growth retardation and premature aging.(85) However, expression of D40 does not affect wild-type p53 levels, and while some p53 target genes are hyperactivated, a subset…”
BackgroundDistinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533
Self-citationParant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · cited 1×
“5), and this lethality is again fully rescued by p53 deficiency.(11,12,14) Subsequent studies using Mdm2 and Mdmx conditional mouse strains further revealed the necessity of regulating p53 in various tissues, including the heart, haematopoietic system, skin, bone, and neuroepithelium, where p53 activation causes incre…”
BackgroundThe p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Cited by
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Mello, S. S., Valente, L. J., Raj, N., Seoane, J. A., Flowers, B. M., McClendon, J., Bieging-Rolett, K. T., Lee, J., Ivanochko, D., Kozak, M. M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.007 · Cited by 179
“Although hyperactive p53mutants have been described previously (reviewed in Van Nostrand and Attardi, 2014), the p5353,54 mutant is unique in displaying enhanced tumor suppressor capability.”
InfluentialSelf-citationMultifaceted role for p53 in pancreatic cancer suppression
Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55
Self-citation
Metadata
- Authors
- Van Nostrand, J. L., & Attardi, L. D.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2014-12-15
- Volume
- 13
- Issue
- 24
- Pages
- 3798-3807
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2076489829
- Cited by
- 23
- References
- 22
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guilty as CHARGED: p53's expanding role in disease. https://app.cochat.ai/papers/10.4161/15384101.2014.987627
- The paper
- Van Nostrand, J. L., & Attardi, L. D. (2014). Guilty as CHARGED: p53's expanding role in disease. Cell Cycle. https://doi.org/10.4161/15384101.2014.987627
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.